Tag | Content |
---|
EnhancerAtlas ID | HS023-20371 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr5:96344620-96346260 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr5:96345878-96345896 | CCCTCTTCCCTTTCTTCC | - | 6.11 | STAT1 | MA0137.3 | chr5:96345202-96345213 | TTTCTAGGAAA | + | 6.14 | Stat4 | MA0518.1 | chr5:96345202-96345216 | TTTCTAGGAAAAGA | + | 6.1 | ZNF263 | MA0528.1 | chr5:96345881-96345902 | TCTTCCCTTTCTTCCTCCCTC | - | 7.5 | ZNF263 | MA0528.1 | chr5:96345878-96345899 | CCCTCTTCCCTTTCTTCCTCC | - | 7.92 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_18779 | chr5:96344450-96345759 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr5 | 96345000 | 96345535 | chr5 | 96345045 | 96345609 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH05I097008 | chr5 | 96344650 | 96345897 |
|
Enhancer Sequence | GCTGGGATTA CAAGCGTGAG CCACTGTGCC CACCCTCCTC TTTACTCTTT ACCTGAGTTT 60 ATTCTGAGCT TGTTGAGCTC TTTTTGAGAG TTTAACCCCA TAGACTAGCT CATATTTTAC 120 TGCTTTAGCC TTCTAGGCCC TTACCTGGCA TTCTGTGCTT TTGCCGCACA AAAATTCTAT 180 CAGCAACTCA AACATGCCAT ACTGCCTCTT TAGGTCTTTG CATATGCTAT TTTCTCTCCT 240 TAAGGAACAC CCTTGCCTCC TCACTCCCTC GGCCTACTCC TGTTTATTCT TCAGATCTTA 300 GCTCAGCCAT TGCTTGCTCC AGGAAACCTT TCCTTCCCTG AAGACAGTTT AGATGCCCTA 360 CTTAGGTTTT TTAATAACAT TCTCTACTTC TCCACTCATA ATATACTGTA AGTACTGTTC 420 ACTCATATCT ATCCTCATAT TAGGTATTTC CCCCATTGAC GGTAGTGATC ATGGCTATAT 480 GAATCACTGT AAATCACTTT TAGCACTTAG TAGGCACACA AAAACTTAAT GAATTAGTAA 540 ATTTTAGTCC ATAATGAAGT GACTCCAGTC TCACTATAAA AATTTCTAGG AAAAGAACAT 600 GCAAAGCCTG ATAAAATGAT GTTTTCTTTT TCTCTTCCTC TTCTTAGTAA AGAGGAATAT 660 ACAAAATTCA CTAGAATATA ATTGATTTAA TCTAGAGCTG GAACTGGGCC AATACATGAT 720 GAAAGTAGTG TCTGTTACTT CCTCTTCTCA ACTGTGTTAT TTCCCTTGCT GCTGCTGCTG 780 CTATTTTAAT TCCTGCCATT TCGGGTTTAG AGAGTCCACA TGAAAACTTC TGTCCTTACG 840 TTTGACCCTG AGGACAGCTG AGCCTTCTTG GTTCCTAATG CTCCAGTGAG AATTACTCTT 900 AATTTAACTG CATTTTTATT TTTTCTATTC TCAAAAGAAA GGTAGCAGAG AGGGTGACTT 960 CAGGCTTCTT TTATGCTGTA ATACTTTAGT ATAGTGTATT ATTTTGATGC TTGATGGTTG 1020 GTTAAATCTT TAATATATTT TCTTTCTTTT TTTAAATATA TTTTCATGTG TTCTAATTCA 1080 AGGGTTGTTG GGTTAGTTCA TTAGTTCAGT TGTATATAAG AGTTATGTTT GGTCAATGTA 1140 TTTGTCTCCT TTTCTCACAT ACATGAGTTT TGAACAATTA GTATTTATTG TGCACAAGAA 1200 ATGCTGATGG GGCCATTTTT CCAGTTTACA TATTGAGGAA TTATATTTTT TAAAGTTTCC 1260 CTCTTCCCTT TCTTCCTCCC TCTCTCTCTC TCTTTCTTAT CCACATTTTA CTCAGACCTA 1320 AGATCTTTAA CTATAGGAGA TTTTCGTATT AAATCTAATG CAAAACATTC ATGTTTCCAA 1380 ATGGATATCA CTATCAGAAA TACTGCTGTG AAAGTTAAAG ATATGTCATT GGAAGAAAAG 1440 GTAATTAGGA TGAAAGAAGG AAGGGCATAT AGTAATTAAA ATATTTATCA TGTGCCATTC 1500 TCTGCTCTTG CCTTTTTTTC CCCTAATAAA GGAGAAAGAA AGGGGTATTA GAGAAGGGAA 1560 TGCTTTTGAA CAGGAGTGAT AAAGTTCAAT AGCATGTATG ATGCTAGCCC TCTGGAGCAA 1620 ACTGTACAGG AAATTTTGTA 1640
|